...If the de novo is declined, the device remains in class III and may not be marketed.
https://www.fda.gov/downloads/Medic...onandGuidance/GuidanceDocuments/UCM273903.pdf
page 5 section 3
- Forums
- ASX - By Stock
- RAP
- Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest
Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-159
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)